The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Biometric authentication for concert tickets? Following a multitude of pricing controversies in the secondary ticketing world ...

Axis Capital Holdings Ltd (NYSE:AXS) is set to release its Q4 2024 earnings on Jan 29, 2025. The consensus estimate for Q4 ...

AXS, a global leader in ticketing, and the Indian Wells Tennis Garden, home of the iconic BNP Paribas Open, announced today a partnership renewal. All tickets to the BNP Paribas Open are digital and ...

Here's why the latest SRAM RED group elevates the ride experience and justifies its top-tier positioning. Plus, we weighed ...

Late-stage pipeline milestones include AXS-07 for migraine (PDUFA: January 31, 2025), AXS-12 for narcolepsy, and AXS-14 for fibromyalgia. Despite mixed Phase 3 results for AXS-05 in Alzheimer's ...

AXS, a leading digital ticketing platform, has implemented new biometric authentication capabilities that enable users to access their tickets using fingerprint and facial recognition. The feature, ...

ACCORD-2 Phase 3 trial in Alzheimer’s disease agitation achieves primary endpoint compared to placebo (p=0.001, time to relapse) ACCORD-2 Phase 3 trial achieves key secondary endpoint compared ...

Despite a recent setback with the ADVANCE-2 trial, the company has demonstrated alignment with FDA requirements through comprehensive data that supports the approval of its AXS-05 drug.